Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C14H13N5O5S2 |
| Molecular Weight | 395.414 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 3 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1OC(=O)C2=C1CS[C@@H]3[C@H](NC(=O)C(=N/O)\C4=CSC(N)=N4)C(=O)N23
InChI
InChIKey=UEHIFMGCXPDQOP-CXMNRGBSSA-N
InChI=1S/C14H13N5O5S2/c1-4-5-2-25-12-8(11(21)19(12)9(5)13(22)24-4)17-10(20)7(18-23)6-3-26-14(15)16-6/h3-4,8,12,23H,2H2,1H3,(H2,15,16)(H,17,20)/b18-7-/t4?,8-,12-/m1/s1
| Molecular Formula | C14H13N5O5S2 |
| Molecular Weight | 395.414 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 3 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.clearsynth.com/en/CST10734.html
Sources: https://www.clearsynth.com/en/CST10734.html
There is no information related the biological and pharmacological application of cefdinir lactone but it’s known that this compound is an admixture of cefdinir, that is why it’s also called as cefdinir impurity E.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:43:08 GMT 2025
by
admin
on
Mon Mar 31 21:43:08 GMT 2025
|
| Record UNII |
0W2W754Q55
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
0W2W754Q55
Created by
admin on Mon Mar 31 21:43:08 GMT 2025 , Edited by admin on Mon Mar 31 21:43:08 GMT 2025
|
PRIMARY | |||
|
87815632
Created by
admin on Mon Mar 31 21:43:08 GMT 2025 , Edited by admin on Mon Mar 31 21:43:08 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |